Bakheit AM - Search Results

1

The profile of patients and current practice of treatment of upper limb muscle spasticity with botulinum toxin type A: an international survey.

Bakheit AM, Zakine B, Maisonobe P, Aymard C, Fhedoroff K, Hefter H, Jacinto J, Jost WH, Molteni F, Stam H, Turner-Stokes L, Wissel J. Bakheit AM, et al. Int J Rehabil Res. 2010 Sep;33(3):199-204. doi: 10.1097/MRR.0b013e328332f5e0. Int J Rehabil Res. 2010. PMID: 20154631

2

Classification of posture in poststroke upper limb spasticity: a potential decision tool for botulinum toxin A treatment?

Hefter H, Jost WH, Reissig A, Zakine B, Bakheit AM, Wissel J. Hefter H, et al. Among authors: bakheit am. Int J Rehabil Res. 2012 Sep;35(3):227-33. doi: 10.1097/MRR.0b013e328353e3d4. Int J Rehabil Res. 2012. PMID: 22555318

3

The use of botulinum toxin for the treatment of muscle spasticity in the first 2 years of life.

Bakheit AM. Bakheit AM. Int J Rehabil Res. 2010 Jun;33(2):104-8. doi: 10.1097/MRR.0b013e32832c1e91. Int J Rehabil Res. 2010. PMID: 19574925 Review.

4

A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke.

Bakheit AM, Thilmann AF, Ward AB, Poewe W, Wissel J, Muller J, Benecke R, Collin C, Muller F, Ward CD, Neumann C. Bakheit AM, et al. Stroke. 2000 Oct;31(10):2402-6. doi: 10.1161/01.str.31.10.2402. Stroke. 2000. PMID: 11022071 Clinical Trial.

5

A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.

Bakheit AM, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, Coxon L. Bakheit AM, et al. Eur J Neurol. 2001 Nov;8(6):559-65. doi: 10.1046/j.1468-1331.2001.00277.x. Eur J Neurol. 2001. PMID: 11784339 Clinical Trial.

6

Safety profile and efficacy of botulinum toxin A (Dysport) in children with muscle spasticity.

Bakheit AM, Severa S, Cosgrove A, Morton R, Roussounis SH, Doderlein L, Lin JP. Bakheit AM, et al. Dev Med Child Neurol. 2001 Apr;43(4):234-8. doi: 10.1017/s0012162201000445. Dev Med Child Neurol. 2001. PMID: 11305399 Free article.

7

Creating the optimal conditions for rehabilitation research.

Bakheit AM. Bakheit AM. Int J Rehabil Res. 2009 Sep;32(3):185-8. doi: 10.1097/mrr.0b013e3283298180. Int J Rehabil Res. 2009. PMID: 19685576

8

A study of the effectiveness of botulinum toxin type A (Dysport) in the management of muscle spasticity.

Watanabe Y, Bakheit AM, McLellan DL. Watanabe Y, et al. Among authors: bakheit am. Disabil Rehabil. 1998 Feb;20(2):62-5. doi: 10.3109/09638289809166055. Disabil Rehabil. 1998. PMID: 9494039

9

Effective teamwork in rehabilitation.

Bakheit AM. Bakheit AM. Int J Rehabil Res. 1996 Dec;19(4):301-6. doi: 10.1097/00004356-199612000-00002. Int J Rehabil Res. 1996. PMID: 8982799 Review. No abstract available.

10

A retrospective study to assess resource utilization and costs in patients with post-stroke spasticity in the United Kingdom.

Raluy-Callado M, Cox A, MacLachlan S, Bakheit AM, Moore AP, Dinet J, Gabriel S. Raluy-Callado M, et al. Among authors: bakheit am. Curr Med Res Opin. 2018 Jul;34(7):1317-1324. doi: 10.1080/03007995.2018.1447449. Epub 2018 Mar 29. Curr Med Res Opin. 2018. PMID: 29490512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters